- |||||||||| parogrelil (INDI 702) / Taisho
Meta-analysis on Individual Patient Data from Randomized Controlled Trials of Fortasyn Connect in Early Alzheimer (In-Person) - Jul 6, 2023 - Abstract #AAIC2023AAIC_6857;
The total body of evidence available from RCTs suggests that Fortasyn Connect has a favorable effect on cognition and memory in early AD without any safety concerns, and consequently that this intervention is a viable option in the management of MCI due to AD (prodromal AD) and mild AD. Trial registration: clinicaltrialregister.nl (Souvenir I: NTR702; Souvenir II: NTR1975; LipiDiDiet: NTR1705).
|
